Lind Global Fund II LP 13D and 13G filings for Kiora Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-13 8:08 pm Purchase |
2023-12-31 | 13G | Kiora Pharmaceuticals, Inc. KPRX |
Lind Global Fund II LP | 93,889 9.900% |
55,499 (+144.57%) |
Filing |
| 2023-06-13 4:02 pm Purchase |
2023-06-06 | 13G | Kiora Pharmaceuticals, Inc. KPRX |
Lind Global Fund II LP | 38,390 9.900% |
21,382 (+125.72%) |
Filing |
| 2023-02-13 4:38 pm Purchase |
2022-12-31 | 13G | Kiora Pharmaceuticals, Inc. KPRX |
Lind Global Fund II LP | 17,008 7.900% |
17,008 (New Position) |
Filing |